基于SWOT分析法的区域性肝病临床病理研究中心建设策略

汤鸿; 徐蓉蓉; 蒋丽琳; 陆忠华

doi:10.3969/j.issn.1001-5256.2019.07.031

基于SWOT分析法的区域性肝病临床病理研究中心建设策略

DOI: 10.3969/j.issn.1001-5256.2019.07.031

南京医科大学附属无锡第二医院病理科
南京医科大学附属无锡第五人民医院肝病科

基金项目:

无锡市科协重点软课题点上项目(KX-18-B09)；

详细信息

中图分类号: R575
计量
- 文章访问数: 864
- HTML全文浏览量: 12
- PDF下载量: 193
- 被引次数: 0
出版历程
- 出版日期: 2019-07-20

A study of construction strategy for regional clinical pathology center of liver disease based on SWOT analysis

Department of Pathology, The Affiliated Wuxi No.2 People's Hospital of Nanjing Medical University

Research funding:

摘要

摘要: <正>肝脏疾病遍布全球,当前与临床治疗密切的研究热点主要集中于病毒性肝炎、非酒精性脂肪性肝病、酒精性肝病、胆汁淤积性肝病、肝细胞癌、急性或慢加急性肝衰竭[1]。我国是病毒性肝炎和肝脏肿瘤的高发国家之一,近年来对肝病的防治与研究发展较快,但因起步较晚,存在分段管理、各自为政、各级医院诊疗水平参差不齐、难以提供规范化优质服务的缺陷,疾病
- 肝疾病 /
- SWOT分析法 /
- 病理学,临床
- liver diseases /
- swot analytical method /
- pathology, clinical

HTML全文

参考文献(16)

[1]ZHANG N, HU JH.The 69th annual meeting of the American association for the study of liver diseases 2018 hot spots[J].Inter J Epidemiol Infect Dis, 2018, 45 (6) :451-452. (in Chinese) 张宁, 胡瑾华.2018年第69届美国肝病研究学会年会热点[J].国际流行病学传染病学杂志, 2018, 45 (6) :451-452.

[2]JIA JD, WEI L, HOU JL, et al.Chinese standards for diagnosis and treatment of liver disease-White paper excerpt[J].JClin Hepatol, 2014, 30 (3) :197-209. (in Chinese) 贾继东, 魏来, 侯金林, 等.《中国肝病诊疗管理规范》白皮书 (节选) [J].临床肝胆病杂志, 2014, 30 (3) :197-209.

[3]World Health Organization.Global hepatitis report, 2017[EB/OL]. (2017-04-21) http://www.who.int/hiv/pub/hepatitis/global-hepatitis-report2017-Excutive-summary/zh/.As Jan 20th, 2019.

[4]National Health and Family Planning Commission, National Development and Reform Commission, Ministry of Education, etc.Notice on the issuance of Action plan for the prevention and treatment of viral hepatitis in China (2017-2020) by National Health and Family Planning Commission, National Development and Reform Commission, Ministry of Education, Ministry of Science and Technology, Ministry of Industry and Information Technology, Ministry of Public Security, Ministry of Finance, Ministry of Human Resources and Social Security, Ministry of Housing and Urban-Rural Development, China Food and Drug Administration, and National Administration of Traditional Chinese Medicine[J].Gazette of the State Council of the People's Republic of China, 2018, (7) :76-82. (in Chinese) 卫生计生委, 发展改革委, 教育部, 等.卫生计生委发展改革委教育部科技部工业和信息化部公安部财政部人力资源社会保障部住房城乡建设部食品药品监管总局中医药局关于印发中国病毒性肝炎防治规划 (2017-2020年) 的通知[J].中华人民共和国国务院公报, 2018, (7) :76-82.

[5]GALAS A, PILAT A, LEONARDI M, et al.Research project evaluation-learnings from the PATHWAYS project experience[J].Int J Eenviron Res Public Health, 2018, 15 (16) :1071.

[6] LI LQ, LU ZX, YIN XX.SWOT analysis on hierarchical medical system in China[J].Chin J Hosp Administration, 2015, 31 (4) :263-265. (in Chinese) 李丽清, 卢祖洵, 殷晓旭.我国分级医疗体系的SWOT分析[J].中华医院管理杂志, 2015, 31 (4) :263-265.

[7]TANG H, ZHANG RR, CAO YX.Standardized construction of molecular pathology laboratory in department of pathology in municipal hospitals:A SWOT analysis[J].Chin J Pathol, 2018, 47 (7) :565-566. (in Chinese) 汤鸿, 张熔熔, 曹岳兴.地市级医院病理科分子病理实验室规范化建设的SWOT分析[J].中华病理学杂志, 2018, 47 (7) :565-566.

[8]TANG H, TANG W, ZHANG RR.A preliminary analysis of the6S management mode in pathology laboratory[J].Chin JPathol, 2013, 42 (11) :789-791. (in Chinese) 汤鸿, 唐威, 张熔熔.病理技术实验室6S管理尝试[J].中华病理学杂志, 2013, 42 (11) :789-791.

[9]TAPPER EB, LOK AS.Use of liver imaging and biopsy in clinical practice[J].N Eng J Med, 2017, 377 (8) :756-768.

[10]KLEINERl DE.Hepatocellular carcinoma:Liver biopsy in the balance[J].Hepatology, 2018, 68 (1) :13-15.

[11]TANG H, ZHANG L, ZHAO W, et al.A case of IgA nephropathy with deep venous throm bosis in the mesentery and lower extremities[J].QIMS, 2018, 8 (11) :1123-1128.

[12]TAN YW, JI HL, LU ZH, et al.Ductopenia and cirrhosis in a32-year-old woman with progressive familial intrahepatic cholestasis type 3:A case report and review of the literature[J].World J Gastroenterol, 2018, 24 (41) :4716-4720.

[13]JIANG LL, SHEN JB, TANG H, et al.Pathological differential diagnosis of inflammatory liver injury[J].J Clin Hepatol, 2018, 34 (11) :2278-2282. (in Chinese) 蒋丽琳, 沈剑波, 汤鸿, 等.炎症性肝损伤的病理学鉴别诊断[J].临床肝胆病杂志, 2018, 34 (11) :2278-2282.

[14] TANG H, LU ZH, ZHANG RR, et al.A liver biopsy specimen model to study the quality improvement and process optimization through failure mode and effects analysis[J].Chin J Hepatol, 2019, 27 (3) :210-212. (in Chinese) 汤鸿, 陆忠华, 张熔熔, 等.基于失效模式与效应分析理论的肝活检组织标本质量提升与流程优化模型研究[J].中华肝脏病杂志, 2019, 27 (3) :210-212.

[15]ZHU YW, TANG H, ZHANG LL, et al.Suppression of miR-21-3p enhancesTRAILmediated apoptosis in liver cancer stem cells by suppressing the PI3K/Akt/Bad cascade via regulating PTE[J].Cancer Manag Res, 2019, 11:955-968.

[16]JIANG LN, ZHAO JM.Histological evaluation of liver in chronic hepatitis C after direct-acting antiviral agents treatment[J].Clin J Hepatol, 2018, 26 (3) :184-187. (in Chinese) 蒋丽娜, 赵景民.丙型肝炎直接作用抗病毒药物治疗后的肝组织学评价[J].中华肝脏病杂志, 2018, 26 (3) :184-187.

施引文献

资源附件(0)

访问统计